Stay updated with breaking news from Jonil Rutter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
![[Webinar] The NCATS Alliance: Speeding the Process of Bringing New Treatments to Patients - March 15th, 1:00 pm - 2:00 pm ET | Manatt, Phelps & Phillips, LLP - Vimarsana News](https://jdsupra-static.s3.amazonaws.com/profile-images/hr.858_845.jpg)
Featuring Francis Collins, M.D., Ph.D., Senior Advisor to President Biden and Former Director of the National Institutes of Health, and Joni Rutter, Ph.D., NCATS Director, Plus a Panel...
Leaders from the National Institutes of Health and partner organizations outline NIH's COVID-19 research response in a policy forum in the journal Science.
America’s choices on key health care issues began to take shape overnight as results from several state ballot initiatives and governor’s races were called.
A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept - drugs widely used to treat certain autoimmune diseases - did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths.
RESEARCH TRIANGLE PARK - The nearly 30 million Americans who suffer from rare diseases have received some good news. The National Institutes of Health, the U.S.